Soranzo, N and Sanna, S and Wheeler, E and Gieger, C and Radke, D and Dupuis, J and Bouatia-Naji, N and Langenberg, C and Prokopenko, I and Stolerman, E and Sandhu, MS and Heeney, MM and Devaney, JM and Reilly, MP and Ricketts, SL and Stewart, AFR and Voight, BF and Willenborg, C and Wright, B and Altshuler, D and Arking, D and Balkau, B and Barnes, D and Boerwinkle, E and Bohm, B and Bonnefond, A and Bonnycastle, LL and Boomsma, DI and Boinstein, SR and Bottcher, Y and Bumpstead, S and Burnett-Miller, MS and Campbell, H and Cao, A and Chambers, J and Clark, R and Collins, FS and Coresh, J and de Geus, EJC and Dei, M and Deloukas, P and Doring, A and Egan, JM and Elosua, R and Ferrucci, L and Forouhi, N and Fox, CS and Franklin, C and Franzosi, MG and Gallina, S and Goe, A and Graessler, J and Grallert, H and Greinacher, A and Hadley, D and Hall, A and Hamsten, A and Hayward, C and Heath, S and Herder, C and Homuth, G and Hottenga, JJ and Hunter-Merrill, R and Illig, T and Jackson, AU and Jula, A and Kleber, M and Knouff, CW and Kong, A and Kooner, J and Kottgen, A and Kovacs, P and Krohn, K and Kuhne, B and Kuusisto, J and Laakso, M and Lathrop, M and Lecoeur, C and Li, M and Li, MY and Loos, RJF and Luan, JA and Lyssenko, V and Magi, R and Magnusson, PKE and Malarstig, A and Mangino, M and Martinez-Larrad, MT and Marz, W and McArdle, WL and McPherson, R and Meisinger, C and Meitinger, T and Melander, O and Mohlke, KL and Mooser, VE and Morken, MA and Narisu, N and Nathan, DM and Nauck, M and O'Donne, C and Oexle, K and Olla, N and Pankow, JS and Payne, F and Peden, JF and Pedersen, NL and Peltonen, L and Perola, M and Polasek, O and Porcu, E and Rader, DJ and Rathmann, W and Ripatti, S and Rocheleau, G and Roden, M and Rudan, I and Salomaa, V and Saxena, R and Schlessinger, D and Schunkert, H and Schwarz, P and Seedorf, U and Selvin, E and Serrano-Rios, M and Shrader, P and Silveira, A and Siscovick, D and Song, K and Spector, TD and Stefansson, K and Steinthorsdottir, V and Strachan, DP and Strawbridge, R and Stumvoll, M and Surakka, I and Swift, AJ and Tanaka, T and Teumer, A and Thorleifsson, G and Thorsteinsdottir, U and Tonjes, A and Usalai, G and Vitart, V and Volzke, H and Wallaschofski, H and Waterworth, DM and Watkins, H and Wichmann, HE and Wild, SH and Willemsen, G and Williams, GH and Wilson, JF and Winkelmann, J and Wright, AF and Zabena, C and Zhao, JH and Epstein, SE and Erdmann, J and Hakonarson, HH and Kathiresan, S and Khaw, KT and Roberts, R and Samani, NJ and Fleming, MD and Sladek, R and Abecasis, G and Boehnke, M and Froguel, P and Groop, L and McCarthy, MI and Kao, WHL and Florez, JC and Uda, M and Wareham, NJ and Barroso, I and Meigs, JB and Procardis Consortium, and WTCCC, (2010) Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways. DIABETES , 59 (12) 3229 - 3239. 10.2337/db10-0502.
Full text not available from this repository.
OBJECTIVE-Glycated hemoglobin (HbA(1c)), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated with increased levels of HbA(1c). We aimed to identify such genetic factors and investigate the extent to which they influence diabetes classification based on HbA(1c) levels.RESEARCH DESIGN AND METHODS-We studied associations with HbA(1c) in up to 46,368 nondiabetic adults of European descent from 23 genome-wide association studies (GWAS) and 8 cohorts with de novo genotyped single nucleotide polymorphisms (SNPs). We combined studies using inverse-variance meta-analysis and tested mediation by glycemia using conditional analyses. We estimated the global effect of HbA(1c) loci using a multilocus risk score, and used net reclassification to estimate genetic effects on diabetes screening.RESULTS-Ten loci reached genome-wide significant association with HbA(1c), including six new loci near FN3K (lead SNP/P value, rs1046896/P = 1.6 x 10(-26)), HFE (rs1800562/P = 2.6 x 10(-20)), TMPRSS6 (rs855791/P = 2.7 x 10(-14)), ANK1 (rs4737009/P = 6.1 x 10(-12)), SPTA1 (rs2779116/P = 2.8 x 10(-9)) and ATP11A/TUBGCP3 (rs7998202/P = 5.2 x 10(-9)), and four known HbA(1c) loci: HK1 (rs16926246/P = 3.1 x 10(-54)), MTNR1B (rs1387153/P = 4.0 X 10(-11)), GCK (rs1799884/P = 1.5 x 10(-20)) and G6PC2/ABCB11 (rs552976/P = 8.2 x 10(-18)). We show that associations with HbA(1c) are partly a function of hyperglycemia associated with 3 of the 10 loci (GCK, G6PC2 and MTNR1B). The seven nonglycemic loci accounted for a 0.19 (%HbA(1c)) difference between the extreme 10% tails of the risk score, and would reclassify similar to 2% of a general white population screened for diabetes with HbA(1c).CONCLUSIONS-GWAS identified 10 genetic loci reproducibly associated with HbA(1c). Six are novel and seven map to loci where rarer variants cause hereditary anemias and iron storage disorders. Common variants at these loci likely influence HbA(1c) levels via erythrocyte biology, and confer a small but detectable reclassification of diabetes diagnosis by HbA(1c) Diabetes 59: 3229-3239, 2010
|Title:||Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways|
|Keywords:||NONSPHEROCYTIC HEMOLYTIC-ANEMIA, FASTING GLUCOSE-LEVELS, TYPE-2 DIABETES RISK, GENETIC HEMOCHROMATOSIS, BLOOD-CELLS, ASSOCIATION, MTNR1B, RECLASSIFICATION, POLYMORPHISM, PREVALENCE|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health Care > Epidemiology and Public Health|
Archive Staff Only: edit this record